Hot Features
プレミアム
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dr. Laurent FischerIndependent Director | 3.98k | 0.00 | Derivative Exercise and Retained Stock | - | 10.73k | 58.92% |
| 2026-05-29 | Dr. Lon CardonIndependent Director | 3.98k | 0.00 | Derivative Exercise and Retained Stock | - | 9.68k | 69.74% |
| 2026-05-29 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -3.98k | 397.70k | Derivative Exercise and Sale | 100.00 | - | - |
| 2026-05-29 | Mr. Timothy P. WalbertIndependent Director | 3.98k | 0.00 | Derivative Exercise and Retained Stock | - | 9.68k | 69.74% |
| 2026-05-15 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2.00k | 171.92k | Derivative Exercise and Sale | 23.51 - 109.47 | 0.00 | - |
| 2026-04-15 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2.00k | 146.78k | Derivative Exercise and Sale | 23.51 - 96.90 | 0.00 | - |
| 2026-03-15 | Mr. Eric H. BjerkholtCFO | 6.05k | 0.00 | Derivative Exercise and Retained Stock | - | 49.79k | 13.82% |
| 2026-03-15 | Mr. Eric H. BjerkholtCFO | -7.29k | 670.24k | Derivative Exercise and Sale | 91.98 | 49.79k | - |
| 2026-03-16 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2.00k | 134.50k | Derivative Exercise and Sale | 23.51 - 90.76 | - | - |
| 2026-03-15 | Mr. Peter RadovichCOO & President | 13.71k | 0.00 | Derivative Exercise and Retained Stock | - | 40.27k | 51.59% |
| 2026-03-15 | Mr. Peter RadovichCOO & President | -16.52k | 1.52M | Derivative Exercise and Sale | 91.98 | 40.27k | - |
| 2026-03-15 | Ms. Jolanda HoweSenior VP & Global Controller | 3.93k | 0.00 | Derivative Exercise and Retained Stock | - | 8.43k | 87.19% |
| 2026-03-15 | Ms. Jolanda HoweSenior VP & Global Controller | -4.73k | 435.24k | Derivative Exercise and Sale | 91.98 | 8.43k | - |
| 2026-03-15 | Dr. Joanne M. J. QuanChief Medical Officer | 6.05k | 0.00 | Derivative Exercise and Retained Stock | - | 18.86k | 47.18% |
| 2026-03-15 | Dr. Joanne M. J. QuanChief Medical Officer | -7.29k | 670.24k | Derivative Exercise and Sale | 91.98 | 18.86k | - |
| 2026-03-15 | Mr. Christopher PeetzCEO & Director | 34.02k | 0.00 | Derivative Exercise and Retained Stock | - | 381.81k | 9.78% |
| 2026-03-15 | Mr. Christopher PeetzCEO & Director | -40.99k | 3.77M | Derivative Exercise and Sale | 91.98 | 381.81k | - |
| 2026-03-06 | Mr. Peter RadovichCOO & President | 5.91k | 93.82k | Derivative Exercise and Retained Stock | 15.87 | 26.57k | 28.62% |
| 2026-02-13 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2.00k | 157.16k | Derivative Exercise and Sale | 23.51 - 102.09 | 0.00 | - |
| 2026-01-31 | Ms. Jolanda HoweSenior VP & Global Controller | 803.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.50k | 21.70% |
| 2026-01-31 | Ms. Jolanda HoweSenior VP & Global Controller | -968.00 | 100.00k | Derivative Exercise and Sale | 103.30 | 4.50k | - |
| 2026-02-02 | Mr. Christopher PeetzCEO & Director | -9.11k | 940.89k | 売り | 103.30 | 347.79k | -2.55% |
| 2026-02-02 | Mr. Peter RadovichCOO & President | -2.63k | 271.79k | 売り | 103.30 | 20.66k | -11.30% |
| 2026-01-23 | Mr. Christopher PeetzCEO & Director | 5.67k | 0.00 | Derivative Exercise and Retained Stock | - | 340.24k | 1.69% |
| 2026-01-23 | Mr. Christopher PeetzCEO & Director | -6.83k | 657.09k | Derivative Exercise and Sale | 96.19 | 340.24k | - |
| 2026-01-23 | Mr. Peter RadovichCOO & President | 2.61k | 0.00 | Derivative Exercise and Retained Stock | - | 18.47k | 16.43% |
| 2026-01-23 | Mr. Peter RadovichCOO & President | -3.14k | 302.33k | Derivative Exercise and Sale | 96.19 | 18.47k | - |
| 2026-01-23 | Mr. Eric H. BjerkholtCFO | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 43.74k | 3.83% |
| 2026-01-23 | Mr. Eric H. BjerkholtCFO | -1.05k | 101.29k | Derivative Exercise and Sale | 96.19 | 43.74k | - |
| 2026-01-23 | Ms. Jolanda HoweSenior VP & Global Controller | 658.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.70k | 21.63% |
| 2026-01-23 | Ms. Jolanda HoweSenior VP & Global Controller | -842.00 | 80.99k | Derivative Exercise and Sale | 96.19 | 3.70k | - |
| 2026-01-23 | Frazier Life Sciences Management, LP法人 | 131.43k | 9.00M | 買い | 68.48 | 7.09M | 1.89% |
| 2026-01-23 | Frazier Life Sciences Management, LP法人 | 593.86k | 21.03M | 買い | 68.48 | 1.14M | 108.97% |
| 2026-01-21 | Dr. Joanne M. J. QuanChief Medical Officer | 1.51k | 0.00 | Derivative Exercise and Retained Stock | - | 12.82k | 13.37% |
| 2026-01-21 | Dr. Joanne M. J. QuanChief Medical Officer | -1.82k | 170.04k | Derivative Exercise and Sale | 93.33 | 12.82k | - |
| 2026-01-21 | Ms. Jolanda HoweSenior VP & Global Controller | 616.00 | 0.00 | Derivative Exercise and Retained Stock | - | 3.04k | 25.39% |
| 2026-01-21 | Ms. Jolanda HoweSenior VP & Global Controller | -926.00 | 86.42k | Derivative Exercise and Sale | 93.33 | 3.04k | - |
| 2026-01-21 | Mr. Peter RadovichCOO & President | -2.38k | 222.30k | Derivative Exercise and Sale | 93.33 | 11.68k | - |
| 2026-01-21 | Mr. Peter RadovichCOO & President | 1.79k | 0.00 | Derivative Exercise and Retained Stock | - | 11.68k | 18.04% |
| 2026-01-21 | Mr. Eric H. BjerkholtCFO | 1.91k | 0.00 | Derivative Exercise and Retained Stock | - | 42.13k | 4.76% |
| 2026-01-21 | Mr. Eric H. BjerkholtCFO | -1.42k | 132.62k | Derivative Exercise and Sale | 93.33 | 42.13k | - |
| 2026-01-21 | Mr. Christopher PeetzCEO & Director | 5.70k | 0.00 | Derivative Exercise and Retained Stock | - | 334.57k | 1.73% |
| 2026-01-21 | Mr. Christopher PeetzCEO & Director | -7.10k | 662.42k | Derivative Exercise and Sale | 93.33 | 334.57k | - |
| 2026-01-16 | Dr. Joanne M. J. QuanChief Medical Officer | 5.59k | 0.00 | Derivative Exercise and Retained Stock | - | 11.31k | 97.78% |
| 2026-01-16 | Dr. Joanne M. J. QuanChief Medical Officer | -6.91k | 623.85k | Derivative Exercise and Sale | 90.27 | 11.31k | - |
| 2026-01-15 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2.00k | 134.96k | Derivative Exercise and Sale | 23.51 - 90.99 | 0.00 | - |
| 2025-12-31 | Mr. Christopher PeetzCEO & Director | -21.07k | 0.00 | Other Disposition | - | 331.16k | -5.98% |
| 2025-12-22 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -5.00k | 282.45k | Derivative Exercise and Sale | 23.51 - 80.00 | 0.00 | - |
| 2025-12-19 | Mr. Michael G. GreyIndependent Non-Executive Chairman of the Board | -50.00k | 3.75M | Derivative Exercise and Sale | 2.94 - 78.00 | 280.16k | - |
| 2025-12-18 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -2.00k | 92.44k | Derivative Exercise and Sale | 23.51 - 70.00 | 0.00 | - |
| 2025-12-01 | Mr. Michael G. GreyIndependent Non-Executive Chairman of the Board | -50.00k | 3.55M | Derivative Exercise and Sale | 2.94 - 74.00 | 280.16k | - |
| 2025-11-21 | Mr. Michael G. GreyIndependent Non-Executive Chairman of the Board | -50.00k | 3.35M | Derivative Exercise and Sale | 2.94 - 70.00 | 280.16k | - |
| 2025-11-18 | Mr. Christopher PeetzCEO & Director | 19.13k | 368.12k | Derivative Exercise and Retained Stock | 19.24 | 349.31k | 5.79% |
| 2025-11-01 | Frazier Life Sciences Public Overage Fund, L.P.法人 | -940.57k | 0.00 | 売り | - | 0.00 | -100.00% |
| 2025-11-01 | Frazier Life Sciences Management, LP法人 | 940.57k | 0.00 | 買い | - | 2.51M | 59.74% |
| 2025-09-11 | Mr. Eric H. BjerkholtCFO | 8.76k | 0.00 | Derivative Exercise and Retained Stock | - | 39.95k | 28.07% |
| 2025-09-11 | Mr. Eric H. BjerkholtCFO | -9.58k | 728.02k | Derivative Exercise and Sale | 76.01 | 39.95k | - |
| 2025-09-11 | Ms. Laura A. BregeIndependent Director | -17.00k | 1.01M | Derivative Exercise and Sale | 15.00 - 75.07 | 15.70k | - |
| 2025-09-08 | Ms. Sona Saira Gonsalves RamasastryIndependent Director | -17.00k | 399.67k | Derivative Exercise and Sale | - | 0.00 | - |
| 2025-08-12 | Mr. Eric H. BjerkholtCFO | 2.95k | 78.25k | Derivative Exercise and Retained Stock | 26.49 | 31.19k | 10.46% |
| 2025-08-11 | Mr. Eric H. BjerkholtCFO | -8.00k | 0.00 | 売り | - | 31.19k | -20.41% |
| 2025-08-11 | Mr. Christopher PeetzCEO & Director | -40.00k | 2.36M | Derivative Exercise and Sale | 2.94 - 62.00 | 324.29k | - |
| 2025-08-07 | Ms. Jolanda HoweSenior VP & Global Controller | -10.00k | 517.30k | Derivative Exercise and Sale | 6.27 - 58.00 | 2.43k | - |
| 2025-08-07 | Mr. Christopher PeetzCEO & Director | -40.00k | 2.09M | Derivative Exercise and Sale | 2.94 - 55.25 | 324.29k | - |
| 2025-07-01 | Ms. Jolanda HoweSenior VP & Global Controller | -1.04k | 50.62k | Derivative Exercise and Sale | 48.25 - 49.08 | 2.43k | - |
| 2025-06-11 | Mr. William Carl FaireyIndependent Director | -3.20k | 155.09k | 売り | 48.42 | 2.50k | -56.16% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
